In cancer, dysregulated miRNA expression can lead to increased levels of miRNAs that target PTEN. This results in decreased PTEN protein levels, even in the presence of PTEN mRNA, thereby promoting oncogenic signaling through the PI3K/Akt pathway. The gene discussed is AKT1; the disease is cancer.